Hemolytic Anemia Due to Red Cell Trauma

Slide 1 · Hemolytic Anemia Due to

Red Cell Trauma

Mechanical injury, microangiopathy and clinicopathologic interpretation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain mechanical fragmentation as a cause of intravascular hemolysis.

Compare valve-associated trauma with microangiopathic injury.

Interpret fragmented erythrocytes in the context of DIC, TTP and HUS.

Connect red cell lysis with plasma, urinary and marrow consequences.

Slide 3 · Where traumatic hemolysis fits

Anemia from increased red cell destruction

Mechanical trauma is an acquired, nonimmune hemolytic mechanism.

It belongs alongside immunologic, infectious and toxic causes of red cell loss.

The distinction is the mechanism—not simply the degree of anemia.

Slide 4 · Definition: Trauma-induced hemolytic anemia

Circulating erythrocytes are damaged by mechanical forces.

Fragmentation may precede or accompany intravascular cell lysis.

The cause usually lies in vascular or cardiac flow conditions—not an intrinsic erythrocyte defect.

Unifying idea

Abnormal flow environment → membrane injury → premature red cell destruction.

Slide 5 · The two principal clinical settings

Prosthetic cardiac valves

Microangiopathic disorders

Abnormal turbulent flow.

Pressure gradients across damaged valves.

Mechanical valves more often implicated than tissue valves.

Pathologic narrowing of small vessels.

Often related to microthrombi.

Passing red cells are subjected to shear stress.

Slide 6 · Why mature erythrocytes are vulnerable

Red cells repeatedly traverse vessels under dynamic pressure and flow.

Normal deformability is necessary for passage through small vascular spaces.

Severe deformation against pathologic obstacles damages the membrane.

RBC fragments are a morphologic footprint of physical injury.

Slide 7 · Hemolysis: Intravascular versus extravascular

Intravascular

Extravascular

Red cells lyse within the circulating blood.

Free hemoglobin enters plasma.

Hemoglobinuria and hemosiderinuria may occur.

Red cells are removed by tissue macrophages.

Splenic sequestration is prominent in many causes.

Splenomegaly is a characteristic clue.

Slide 8 · Core mechanism of red cell trauma

Abnormal valve or narrowed vessel

Mechanical shear stress

Membrane fragmentation

Intravascular hemolysis

An acquired injury mechanism imposed on circulating red cells.

Slide 9 · The importance of shear stress

Flow-associated forces deform erythrocytes as they encounter pathologic narrowing.

Excessive stress can tear the membrane or produce irregular fragments.

The same principle applies in mechanical valves and microangiopathies.

Mechanistic inference

The abnormal structure generates the forces; The RBC is the injured target.

Slide 10 · Valve-related mechanical injury: Conceptual geometry

Simplified vessel cross-section (schematic)

Turbulent flow near altered valve geometry

Not an anatomical-scale rendering or patient image

Slide 11 · Microvascular narrowing and erythrocyte fragmentation

Simplified vessel cross-section (schematic)

Microvascular narrowing / thrombotic material

Not an anatomical-scale rendering or patient image

Slide 12 · From physical damage to visible fragmentation

RBC encounters narrowing

Membrane deforms under shear

Cell fragments separate

Schistocytes appear on smear

Schistocytes reflect the mechanics of the circulating microenvironment.

Slide 13 · Valve-associated hemolysis

Mechanical prosthetic valves carry greater risk

Mechanical prostheses with porcine or bovine bioprostheses.

The association is with nonphysiologic flow and shear—not antibody binding.

Valve damage can intensify pressure gradients and turbulent flow.

Slide 14 · Mechanical versus tissue prostheses

Mechanical prosthesis

Porcine or bovine bioprosthesis

Artificial device in the bloodstream.

Relatively more frequently implicated in mechanical hemolysis.

Can create high shear under abnormal flow conditions.

Biological replacement valve tissue.

Less frequently implicated in the cited Robbins passage.

Still requires clinical assessment if abnormal flow develops.

Slide 15 · How a damaged valve causes hemolysis

Valve geometry or function altered

Turbulent flow / pressure gradient

Repeated RBC mechanical trauma

Hemolysis with fragments

Valve hemodynamics explain the morphologic pattern.

Slide 16 · Valve-associated pattern: What to infer

Evidence of intravascular hemolysis should prompt consideration of a mechanical source.

The clinical history of prosthetic valve implantation is diagnostically relevant.

Schistocytes signal fragmentation but do not alone prove valve dysfunction.

Slide 17 · Case application: Prosthetic valve

Hypothetical case

A patient with a mechanical valve develops anemia and a fragmented-cell blood film.

Interpret the findings

Which broad hemolytic mechanism is suggested?

What flow abnormalities explain this morphology?

What alternative microvascular processes should remain in consideration?

Slide 18 · What is microangiopathic hemolytic anemia?

Mechanical RBC injury within diseased small vessels

Microvascular lesions narrow the vascular lumen.

Thrombi frequently contribute to the narrowing.

Shear stress fragments passing erythrocytes.

Slide 19 · Microangiopathy: Vascular lesion to anemia

Microvascular lesion

Luminal narrowing

RBC fragmentation

Intravascular hemolytic anemia

The shared final pathway differs from the initiating disease.

Slide 20 · Not all microangiopathic causes are the same

DIC is caused by widespread coagulation activation.

TTP and HUS are thrombotic microangiopathies driven by excessive platelet activation.

Malignant hypertension, systemic lupus erythematosus and disseminated cancer are other listed settings.

Slide 21 · Major triggers of traumatic red cell injury

Clinical setting

Underlying physical abnormality

RBC consequence

Prosthetic cardiac valve

Turbulence / pressure gradient

Fragmentation and hemolysis

DIC

Fibrin-rich microthrombi

Shear in narrowed capillaries

TTP / HUS

Platelet-rich small-vessel thrombi

Fragmentation and hemolysis

Other vascular disorders

Small-vessel injury or obstruction

Microangiopathic fragmentation

Slide 22 · DIC: A common MAHA setting

Excessive systemic activation of coagulation

Disseminated intravascular coagulation produces fibrin deposits in small vessels.

Flow through narrowed microvascular channels can fragment erythrocytes.

Coagulation-factor and platelet consumption also creates a bleeding tendency.

Slide 23 · DIC: Thrombus formation and RBC trauma

Pathologic tissue factor / endothelial injury

Systemic coagulation activation

Microvascular fibrin deposition

RBC fragmentation

Hemolysis is one consequence of a broader thrombohemorrhagic process.

Slide 24 · What triggers DIC?

Sepsis and major tissue injury can promote widespread coagulation activation.

Obstetric complications and malignancy are major clinical associations.

Tissue factor release and diffuse endothelial injury are central mechanisms.

Slide 25 · DIC: Two simultaneous pathologic effects

Microthrombotic injury

Hemorrhagic tendency

Vascular lumina narrow due to fibrin.

Tissue ischemia and organ dysfunction may follow.

RBC fragmentation produces MAHA.

Platelets and coagulation factors are consumed.

Fibrinolysis intensifies bleeding risk.

Patients may have bleeding, thrombosis or both.

Slide 26 · DIC-related tissue injury

Glomerular and other microvascular fibrin thrombi impair perfusion.

The same obstructive lesions can fragment circulating erythrocytes.

The organ-specific manifestations depend on where thrombi accumulate.

Slide 27 · Recognizing DIC in the MAHA differential

Domain

Findings to consider

Underlying context

Sepsis, trauma, obstetric event, malignancy

Blood film

Fragmented erythrocytes / MAHA

Hemostasis

Platelet consumption and altered coagulation studies

Supporting tests

PT, PTT, fibrinogen, fibrin degradation products / D-dimer

Slide 28 · Case application: DIC

Hypothetical case

A patient with severe sepsis develops bleeding, organ dysfunction and fragmented red cells.

Interpret the findings

How can one process produce thrombosis and bleeding?

What mechanism fragments circulating RBCs?

Which hemostasis assays help examine the mechanism?

Slide 29 · Thrombotic microangiopathies

Excessive platelet activation in small vessels

TTP and HUS share platelet-rich microthrombi.

Microangiopathic hemolysis results when red cells traverse the involved vessels.

Platelet consumption contributes to thrombocytopenia.

Slide 30 · Shared thrombotic microangiopathy pathway

Platelet activation

Microvascular platelet thrombi

RBC shear and fragmentation

MAHA + thrombocytopenia

TTP and HUS share the downstream phenotype but not necessarily the same initiating defect.

Slide 31 · TTP: Why ADAMTS13 matters

ADAMTS13 normally cleaves very large von Willebrand factor multimers.

Severe deficiency permits highly adhesive multimers to accumulate.

Uncontrolled platelet aggregation can then form small-vessel thrombi.

Slide 32 · TTP: Enzyme deficiency to fragmentation

Deficient ADAMTS13

Large vWF multimers persist

Platelet microthrombi form

RBC fragmentation + thrombocytopenia

ADAMTS13 is the initiating molecular defect.

Slide 33 · TTP: Acquired versus inherited ADAMTS13 deficiency

Acquired TTP

Inherited TTP

Inhibitory autoantibodies reduce ADAMTS13 activity.

The defect is immune-mediated but RBC injury is mechanical.

Platelet aggregation creates the shear environment.

Inactivating ADAMTS13 mutations are less common.

Clinical presentation may be episodic.

Additional triggers may contribute to overt disease.

Slide 34 · TTP is not defined by its classic pentad

The historical pentad includes fever, thrombocytopenia, MAHA, neurologic change and renal failure.

Many patients do not present with all five findings.

MAHA with thrombocytopenia should raise urgent consideration of TTP.

Slide 35 · TTP: Clinicopathologic urgency

Small-vessel thrombi can produce dysfunction in several organs.

A delayed diagnosis can be fatal.

The Robbins chapter describes plasma exchange as a major therapeutic advance.

The morphology points to a microvascular process; It does not establish the molecular cause by itself.

Slide 36 · Case application: TTP

Hypothetical case

A patient has thrombocytopenia, schistocytes and intermittent neurologic symptoms without the full classic pentad.

Interpret the findings

Should TTP be excluded because the pentad is incomplete?

What enzyme defect explains the disease?

Why does the blood film show fragments?

Slide 37 · HUS: The kidney-centered phenotype

Microangiopathy with prominent renal dysfunction

HUS shares MAHA and thrombocytopenia with TTP.

Acute renal injury is prominent, particularly in classical presentations.

Neurologic manifestations do not provide an absolute separation from TTP.

Slide 38 · Infection-associated HUS

An acquired form follows gastrointestinal infection caused by certain Shiga-toxin-producing E. Coli.

Bloody diarrhea can precede MAHA and acute renal injury.

The precise pathway from bacterial toxin exposure to HUS is not completely established.

Slide 39 · Infection-associated HUS: Clinical sequence

Enteric infection

Bloody diarrhea

Thrombotic microangiopathy

MAHA + thrombocytopenia + renal injury

Sequence is schematic; It does not imply a quantified risk or fixed time interval.

Slide 40 · Complement-associated HUS

Some hereditary forms involve mutations affecting the alternative complement pathway.

Examples include C3, CD46 and complement factors B, H and I.

Poorly controlled complement activation drives susceptibility to recurrent episodes.

Slide 41 · HUS: Distinct initiating mechanisms

Infection-associated form

Complement-mediated form

Trigger: Shiga-like toxin-producing organism.

Frequently follows gastrointestinal disease.

Downstream injury is thrombotic microangiopathy.

Trigger or predisposition: Abnormal complement regulation.

Can recur episodically.

Downstream injury is also thrombotic microangiopathy.

Slide 42 · Other HUS-associated insults

Autoantibodies against complement regulatory factors can be implicated.

Selected drugs, including some chemotherapy agents, may trigger related syndromes.

Radiation and other endothelial injuries can produce similar thrombotic microangiopathies.

Slide 43 · Case application: HUS

Hypothetical case

A child has recent bloody diarrhea, anemia, thrombocytopenia and acute kidney dysfunction.

Interpret the findings

Which MAHA-associated syndrome is suggested?

Which broad initiating factor is implicated?

Why does the peripheral film contain fragments?

Slide 44 · DIC compared with thrombotic microangiopathy

Feature

DIC

TTP / HUS

Dominant process

Coagulation activation

Platelet activation / microthrombi

Hemolysis

Mechanical MAHA

Mechanical MAHA

Platelets

May be consumed

Typically consumed

PT / PTT

Frequently altered

Usually normal

Additional clues

Bleeding + underlying trigger

ADAMTS13 or HUS context

Slide 45 · TTP compared with HUS

Dimension

TTP

HUS

Characteristic trigger

ADAMTS13 deficiency

Infection / complement dysregulation

Microvascular effect

Platelet-rich thrombi

Microvascular platelet thrombi

Blood picture

MAHA + thrombocytopenia

MAHA + thrombocytopenia

Clinical emphasis

Neurologic involvement possible

Renal injury often prominent

Caution

Classic pentad not required

Phenotypes overlap

Slide 46 · Malignant hypertension and red cell trauma

Severe hypertension is included among causes of microangiopathic hemolytic anemia.

Its damaged microvascular bed creates a setting for red cell shear.

The peripheral blood fragmentation reflects vascular injury rather than an intrinsic hemoglobin defect.

Slide 47 · Systemic lupus erythematosus

Systemic lupus erythematosus among clinical settings associated with MAHA.

Immune-mediated vascular injury can coexist with mechanical erythrocyte destruction.

The observed schistocytes identify the final mechanism, not the entire underlying disease.

Slide 48 · Disseminated cancer

Disseminated malignancy is another listed clinical context for red cell trauma.

Microvascular obstruction and thrombotic processes can disturb erythrocyte transit.

Cancer-associated DIC is a related but mechanistically more specific setting.

Slide 49 · Other mechanical trauma

Repetitive physical injury can also lyse red cells

Marathon running, bongo drumming and karate chopping as examples.

These examples illustrate that trauma does not always require a microthrombus.

The current lecture emphasizes prosthetic valves and microangiopathies as the major settings.

Slide 50 · Fragmented erythrocytes: Visual vocabulary

Fragmented cells: Triangular and helmet-like profiles

Schematic only — not a peripheral blood photomicrograph

Slide 51 · What constitutes a schistocyte?

Schistocytes are red cell fragments produced by mechanical disruption.

Irregular, angular profiles provide morphologic evidence of fragmentation.

The blood film should be interpreted alongside hemolysis findings and clinical context.

Slide 52 · Fragment types mentioned by Robbins

Helmet and triangular cells

Burr cells

Profiles reflect physical breakup of the original erythrocyte.

A truncated, angular or pointed outline may be recognizable.

Patterns are best assessed by reviewing the whole smear.

Spiculated profiles are also mentioned.

A burr cell is not synonymous with a classic schistocyte.

Morphology alone does not specify DIC, HUS, TTP or valve injury.

Slide 53 · Why fragmented cells appear on the smear

Pre-existing vascular or valve lesion

Excessive mechanical stress

Portions of RBC are detached

Multiple fragment morphologies

The peripheral smear is a window into an upstream vascular process.

Slide 54 · Blood-film interpretation: Limits

A fragmented red-cell pattern supports mechanical damage.

It cannot distinguish prosthetic valve trauma from DIC, TTP, HUS or other vascular disorders alone.

The causal context comes from history, platelet findings, coagulation studies and organ involvement.

Slide 55 · Plasma hemoglobin and haptoglobin

RBC lyses in the bloodstream

Hemoglobin enters plasma

Haptoglobin binds free hemoglobin

Complexes are cleared; Haptoglobin falls

A mechanistic basis for reduced plasma haptoglobin in intravascular hemolysis.

Slide 56 · Hemoglobinemia and hemoglobinuria

When intravascular lysis releases hemoglobin, plasma binding capacity may become depleted.

Excess free hemoglobin is filtered through the kidneys.

Urine may become reddish-brown from filtered hemoglobin derivatives.

Slide 57 · Renal handling of hemoglobin

Free plasma hemoglobin

Glomerular filtration

Proximal tubular uptake

Renal hemosiderin deposition

With sustained injury, urinary iron loss can contribute to deficiency.

Slide 58 · Bilirubin changes in hemolysis

Hemoglobin breakdown increases heme delivery to phagocytes.

Heme catabolism produces unconjugated bilirubin.

Jaundice may occur; Chronic heme turnover can favor pigment gallstones.

Slide 59 · Marrow compensation and reticulocytosis

Accelerated red cell loss stimulates erythropoietin production.

Bone marrow erythroid precursor activity increases.

Reticulocytes rise when regenerative capacity is preserved.

Anemia persists if RBC destruction exceeds the response.

Slide 60 · Short-term versus persistent intravascular lysis

Acute or marked hemolysis

Prolonged hemolysis

Circulating hemoglobin may appear.

Hemoglobin may be detectable in urine.

Tissue oxygen delivery falls with anemia.

Renal tubular iron can accumulate.

Urinary iron loss may exacerbate anemia.

Marrow compensation continues if able.

Slide 61 · Laboratory and clinical evidence: Mechanism-based

Observation

Pathophysiologic interpretation

Anemia

Premature erythrocyte destruction exceeds replacement

Reticulocytosis

Erythropoietin-driven marrow response

Low plasma haptoglobin

Binding and removal of released hemoglobin

Hemoglobinuria

Filtered hemoglobin during intravascular lysis

Schistocytes

Erythrocyte mechanical fragmentation

Slide 62 · Immune destruction versus mechanical destruction

Immunohemolytic anemia

Traumatic hemolysis

RBC-directed antibodies and/or complement cause injury.

Direct antiglobulin (Coombs) test examines immune coating.

Morphology and hemolysis site vary by immune mechanism.

Physical damage imposed by abnormal flow or narrowed vessels.

Fragmented cells are characteristic.

Clinical cause must be found beyond the blood film.

Slide 63 · A practical etiologic classification

Evidence of intravascular hemolysis and fragmented RBCs

Mechanical valve setting

Evaluate valve-related flow context

Microangiopathy / thrombosis

Assess platelets, organs and coagulation context

Other physical trauma

Use activity/exposure history

Slide 64 · Within microangiopathic hemolysis

Schistocytes with suspected microvascular injury

DIC context

Look for coagulation activation and bleeding

TTP concern

Consider ADAMTS13-driven platelet thrombi

HUS concern

Examine infectious/complement setting and renal injury

Slide 65 · Integrated case: Choose the mechanism

Hypothetical case

Two patients have schistocytes. One has a prosthetic cardiac valve; Another has thrombocytopenia and acute renal dysfunction.

Interpret the findings

Why are the blood films compatible with more than one diagnosis?

What feature separates valve-associated trauma from a thrombotic microangiopathy?

Which further pathologic mechanisms should be evaluated in the second patient?

Slide 66 · Distinguish the cause from the consequence

Underlying cause

Shared consequences

Device-related abnormal flow.

Fibrin or platelet microthrombi.

Vascular damage in systemic disorders.

Mechanical RBC fragmentation.

Intravascular hemolysis and hemoglobin release.

Compensatory erythropoiesis and organ effects.

Slide 67 · Synthesis: One morphology, several mechanisms

Schistocytes are a sign of injury—not a standalone diagnosis

Mechanical valves and microangiopathies are the two major settings emphasized.

DIC, TTP and HUS require different pathophysiologic explanations.

Clinical context plus laboratory and vascular findings identify the cause.

Slide 68 · Primary reference and scope of supporting sections

Robbins, Cotran & Kumar

Pathologic Basis of Disease, 11th edition (2026)

Traumatic hemolysis and schistocytes (Chapter 14).

Parent discussion: intravascular hemolysis and its systemic manifestations.

Related mechanisms: thrombotic microangiopathies and disseminated intravascular coagulation.